期刊文献+

新疆地区血友病患者HBV、HCV和HIV感染调查 被引量:4

A Survey of HBV,HCV and HIV Infections In Hemophilia Patients in Xinjiang Autonomous Region
下载PDF
导出
摘要 目的了解新疆地区血友病患者乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)感染情况。方法对2008年5月~2014年6月新疆血友病诊疗中心确诊或治疗的210例血友病患者进行HBsAg、抗-HCV和抗-HIV检测,并根据年龄段进行分组。结果 210例血友病患者HBsAg、抗-HCV和抗-HIV阳性率分别为2.86%(6/210)、4.29%(9/210)和0.48%(1/210),总感染率为7.63%,不同年龄段患者HBsAg和抗-HCV阳性率的差异有统计学意义。结论新疆地区血友病患者HBV感染率低于一般人群,而HCV感染率高于一般人群,HIV感染有上升趋势,HBV和HCV感染与年龄密切相关。 Objective To understand the prevalence of hepatitis B virus (HBV) , hepatitis C virus (HCV) and human immunodeficiency virus ( HIV) of hemophilia patients in Xinjiang. Methods In 210 hemophilia patients admitted to our hospital from May 2008 to June 2014, serum HBsAg, anti-HCV and anti-HIV were measured. Results The positive rates of HBsAg, anti-HCV and anti-HIV in 210 hemophilia patients were 2.86% (6/210) , 4.29% (9/210)and 0.48% (1/210) , respectively.The overall infection rate was 7.63%. Positive rates of HBsAg and anti-HCV varied in ages of patients Conclusion The prevalence of HBV infection in hemophilia patients in Xinjiang area was lower than that in population of other places of China, and the prevalence of HCV infection in hemophilia patients was even higher. HIV infection tends to be increasing, and HBV and HCV infections in hemophilia patients were closely correlated with age of the pathients.
出处 《临床输血与检验》 CAS 2017年第2期146-148,共3页 Journal of Clinical Transfusion and Laboratory Medicine
  • 相关文献

参考文献5

二级参考文献28

  • 1余滨,王夏,韩荣华,陈载超,陈再芳.武汉市近10年1~3岁儿童乙型肝炎疫苗接种率和乙型肝炎病毒表面抗原携带率调查及发病率分析[J].中国计划免疫,2005,11(2):117-119. 被引量:37
  • 2杨晓光,孔灵芝,翟凤英,马冠生,金水高,中国居民营养与健康状况调查技术执行组.中国居民营养与健康状况调查的总体方案[J].中华流行病学杂志,2005,26(7):471-474. 被引量:174
  • 3丁培芳,申法奎,李继红,马京香,刘德春.甲型血友病患者HBsAg和抗-HCV的初步检测[J].中国输血杂志,1996,9(4):209-209. 被引量:5
  • 4迮文远.计划免疫学(第2版)[M].上海:上海科学技术文献出版社,2002.66.
  • 5Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003, 38(suppl 1)∶s1014-s1118.
  • 6Booth JCL, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut, 2001, 49(suppl 1)∶ s1-s21.
  • 7Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. Gut, 2002, 51∶864-869.
  • 8Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review. Hepatology,2002,36(5 suppl 1)∶s135-s144.
  • 9Di Ciommo V, Russo P, Rava L, et al. Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis. J Viral Hepat, 2003, 10∶210-214.
  • 10Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther, 2003, 18∶1071-1081.

共引文献1044

同被引文献38

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部